Amicus Therapeutics
FOLD
#3908
Rank
A$4.59 B
Marketcap
A$14.90
Share price
-0.50%
Change (1 day)
-1.50%
Change (1 year)

Amicus Therapeutics (FOLD) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.30 Billion

According to Amicus Therapeutics 's latest financial reports the company's total assets are A$1.30 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Amicus Therapeutics - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$1.26 B10.54%
2023-12-31A$1.14 B7.29%
2022-12-31A$1.06 B-14.76%
2021-12-31A$1.24 B8.29%
2020-12-31A$1.15 B-5.06%
2019-12-31A$1.21 B8.29%
2018-12-31A$1.12 B39.62%
2017-12-31A$0.80 B-44.16%
2016-12-31A$1.43 B15.36%
2015-12-31A$1.24 B386.02%
2014-12-31A$0.25 B79.4%
2013-12-31A$0.14 B35%
2012-12-31A$0.10 B55.63%
2011-12-31A$68.06 M-38.57%
2010-12-31A$0.11 B16.59%
2009-12-31A$95.03 M-47.93%
2008-12-31A$0.18 B-4.5%
2007-12-31A$0.19 B152.6%
2006-12-31A$75.66 M93.1%
2005-12-31A$39.18 M
2003-12-31A$0.67 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Biogen
BIIB
A$43.97 B 3,261.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$11.46 B 776.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.54 B-58.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.14 B 9,391.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A$0.31 B-76.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$121.27 B 9,171.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark